Download now: How To Invest in the Coming Bitcoin Boom

Why we’re Investing in Canadian Cannabis Stocks

Canada is 100% going to legalize cannabis

Written by Jeff Siegel
Posted March 24, 2017 at 8:02PM

No matter how far along we come in the quest for cannabis legalization, there are always detractors.

Even today, you can still find prohibitionists and cannabis market bears claiming that Denver dispensaries and going to get shut down and Canada will not approve legalization this year. It’s all just noise, but damn if it isn’t the kind of noise that annoys the shit out of me.

Kind of like Nickelback, but worse.

So I was quite pleased when I saw this tweet today …

mctweet

Anne McLellan is the head of the task force on cannabis legalization and regulation in Canada, and this tweet was posted on the official twitter page of the Canadian National Medical Marijuana Association.

Make no mistake, legalization IS happening in Canada, and investors would be wise to invest accordingly.

While the cannabis industry in the U.S. continues to grow and flourish, Canada remains to be the big story, and the big opportunity. This is actually why nearly all of the cannabis stocks in our portfolio are Canadian.

And rest assured, dear reader, Canada’s foresight and courage will unleash a chain of events that will ultimately help end cannabis prohibition in the U.S. It already has. And this is not only good news for investors, but it’s good news for the sake of a civilized society where sick people can get their medicine, and responsible adults can recreate as they choose, without the fear of being arrested.

Good stuff!

Here’s how our cannabis stocks performed today …

  • Aurora Cannabis (TSX-V: ACB) - Down 0.44%
  • Aphria, Inc. (TSX-V: APH) - Up 1.28%
  • Emblem Corp. (TSX-V: EMC) -  Down 4.22%
  • Emerald Health (TSX-V: EMH) - Up 0.86%
  • Innovative Industrial Properties (NYSE: IIPR) - Down 0.61%
  • OrganiGram (TSX-V: OGI) - Down 3.07%
  • Canopy Growth Corporation (TSX: WEED) - Down 3.05%

Here’s what we’re buying …

Emerald Health (TSX-V: EMH) – Buying below $1.45

And here’s what we’re watching …

Comments

Buffett's Envy: 50% Annual Returns, Guaranteed